SEC Tracker
Get the app

Filana Therapeutics FLNA

Filana Therapeutics wins class certification appeal

Item 8.01 Other events

Form
8-K
Filed
Importance
Routine
  1. Fifth Circuit vacated Texas District Court's class certification order
  2. Appeal challenged class certification for securities purchases between Sep 14, 2020 and Oct 12, 2023
  3. Fifth Circuit said Texas District Court misapplied legal standards
  4. Proceedings will continue in Texas District Court on remand

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Filana Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Anixa Biosciences ANIX public float $85M, Apr 30, 2025, over 18 months old
  2. GENELUX GNLX public float $89M, Jun 30, 2025
  3. Entera Bio ENTX public float $85M, Jun 30, 2025
  4. Immunic IMUX public float $83M, Jun 30, 2025
  5. Coherus Oncology CHRS public float $82M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.